Research Banner Thierry

About us

The Oxford Parkinson's Disease Centre (OPDC) is a unique multidisciplinary research centre at the University of Oxford supported by Parkinson’s UK with funds from The Monument Trust, one of the Sainsbury Family Charitable Trusts.

Established in February 2010, the Oxford Parkinson’s Disease Centre (OPDC) brings together internationally-renowned scientists who work on the genetics of Parkinson’s, the generation of cell and animal models, and the wiring of brain circuits which control movement, with clinical experts in the diagnosis and treatment of Parkinson’s.

Our world-class research centre was formed to understand the earliest events in the development of Parkinson’s and create animal models with greater relevance to the disease, ultimately with a view to identifying the changes which occur before the symptoms become apparent.

Our programme targets the molecular pathways to Parkinson’s in order to:

  1. Understand the progression of Parkinson’s
  2. Predict the onset of Parkinson’s
  3. Identify potential drug targets for Parkinson’s
  4. Develop new treatments that will prevent the development of Parkinson’s in at-risk individuals.
  • Watch the video below to learn more about OPDC's research

 

Selected Publications

News

OPDC open day talks now online

OPDC open day talks now online

Posted 10/10/2017

  Researchers and clinicians from the OPDC hosted members of our cohort and supporters based throughout the Thames valley at an open day of talks and discussion. The event was held in Septmeber 2017 at the Jury's Inn in Oxford with over 200 in attendance. A variety of research topics were discussed including studies of impulse control disorder, sleep issues and  the development of wearable technology to better understand Parkinson's ...


OPDC joins Parkinson's UK 2017 Oxford Walk

OPDC joins Parkinson's UK 2017 Oxford Walk

Posted 29/09/2017

This September, family members of the 2 and 4 legged kind joined the OPDC team for Parkinson’s UK Oxford Walk for Parkinson’s taking on routes between 1.5 and 8 miles around the city raising funds and awareness for the condition. Over 200 Parkinson’s supporters joined the walk and OPDC researchers and clinicans were on hand to talk to walkers about research being carried out to improve our understanding of the condition.  It was a fantastic day ...


Parkinson's 200 plus conference by and for people with Parkinson's to take place in Oxford

Parkinson's 200 plus conference by and for people with Parkinson's to take place in Oxford

Posted 20/07/2017

Parkinson’s UK Oxford Branch have announced a major conference for people with Parkinson’s (PwP) to take place in Oxford on Monday 18 September. Leading experts will discuss the latest developments in the four pillars of Parkinson’s treatment – medicines, exercise, life style and mental health ­– which together offer an improved quality of life for PwP.     “The 200th anniversary of James Parkinson’s essay which first described what he ...

Click here to sign up to the OPDC News Mailing list

Seminars/Events

Brit Mollenhauer 15 Nov 2017

Brit Mollenhauer 15 Nov 2017

Posted 17/07/2017

Brit Mollenhauer is an Assistant Professor and movement disorder specialist with specialty training in neurochemistry. She is an expert in biomarkers for Parkinson's, including assay development and validation with focus on α-synuclein and other proteins. She is a member of executive steering committee of the Parkinson Progression Marker Initiative (PPMI) study (MJFF) and co-chair of the bioanalytics core of PPMI. Dr. Mollenhauer established a ...

Donato A. Di Monte 12 Dec 2017

Donato A. Di Monte 12 Dec 2017

Posted 09/10/2017

12 December 2017, 4pm. Sherrington Library, Sherrington Building, DPAG The primary goal of Professor Di Monte’s research team is to identify mechanisms of neuronal degeneration that could be targeted for the prevention and treatment of human neurodegenerative diseases. Although their research is mainly focused on Parkinson’s disease, they aim to study mechanisms (e.g. protein aggregation and inflammation) and risk factors (e.g. aging) that are ...

 
Med Sci
OUH TrustBRC logoNIHR